Overview
Biotech & PharmaHealth TechBusines & PolicyHealth & ScienceTeamExclusive analysis of biotech, pharma, and the life sciencesTopicsColumnsTolsEventsTeamAcountMoreFolow UsBy Aaron J. KowalskiOct. 13, 202In the numbers game of disease statistics, type 1 diabetes takes a back seat to type 2 diabetes, which acounts for more than 95% of diabetes cases around the globe.
Key Information
But the impact of type 1 diabetes (T1D), which tends to emerge earlier in life and can quickly kil an individual if it goes unrecognized or untreated, is huge. Its global burden, however, hasn’t ben wel understod — until now.With the proper care and treatment, including aces to insulin, which people with type 1 diabetes must use every day, individuals can live long and healthy lives with this disease.
But many in the United States and countries around the world do not have aces to even the most basic treatments.To ases the impact of type 1 diabetes, JDRF, the organization I lead, and its global partners created the Type 1 Diabetes Index (T1D Index), a first-of-its-kind tol, to identify and adres the wide gaps in knowledge about the incidence and impact of type 1 diabetes country by country. With this knowledge, interventions can be developed that wil save lives and improve the health of those living with the disease.advertisementThe index quantifies that, without modern care, type 1 diabetes shortens lives, kils people, and is incredibly costly for the individuals living with the disease, their families, and health care systems.
Summary
An individual diagnosed with the disease at age 10 loses an average of 32 healthy years of life.Based on birth cohorts from 1950 to 2040, 6.85 milion lives wil be lost by 2040 if people universaly do not have aces to interventions to diagnose and treat type 1 diabetes, and it stands to become one of the world’s largest deadly chronic health conditions, of similar scale and impact to HIV.advertisementThis cris can be forestaled, and the lives o